|
?:authorAffiliation
|
-
[\'Great Ormond Street Institute of Child Health, University College London, 30 Guilford Street, London WC1N 1 EH, UK; Great Ormond Street Children\'s Hospital NHS Foundation Trust, Great Ormond Street, London WC1N 3JH, UK. Electronic address: d.goldblatt@ucl.ac.uk.\', \'Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.\', \'Great Ormond Street Institute of Child Health, University College London, 30 Guilford Street, London WC1N 1 EH, UK.\', \'Children\'s Clinical University Hospital, Vienibas gatve 45, Riga LV-1004, Latvia.\', \'UCL Respiratory, Division of Medicine, University College London, London WC1E 6JF, UK.\', \'Dept of Paediatrics & Child Health, Red Cross Children\'s Hospital, and SA-MRC Unit on Child & Adolescent Health, University of Cape Town, South Africa.\', \'Department of Surgery, Duke University Medical Center, Durham, NC, USA.\', \'Vaccine Development and Surveillance, Bill & Melinda Gates Foundation, Seattle, WA, USA.\', \'Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.\', \'Independent Advisor, New York, NY, USA.\', \'Independent Advisor, Stuart, FL, USA.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}